Research Associate Professor, Medical University of South Carolina, United states
Dr. Hong Yu is a Research Associate Professor at the Medical University of South Carolina, specializing in immune response regulation in periodontal disease. With extensive postdoctoral training in microbiology, immunology, and oral health sciences, Dr. Yu has held various faculty and administrative positions, making significant contributions to understanding inflammation and bone loss. 👩🔬🦷
Profile
orcid
Education🎓
M.D., Beijing Medical University, China (1990-1994) Residency in Pathology, People’s Hospital, Beijing Medical University (1990-1995) 🏥 Ivu Wu Fellow, University of Hong Kong (1998-1999) 🌏 Postdoctoral Fellow, Medical University of South Carolina (2000-2009) 📚
Experience👩🏫
Research Assistant Professor, Medical University of South Carolina (2011-2017) 🧑🏫 Research Associate Professor, Medical University of South Carolina (2017-2023) Director of Oral Preclinical Research Facility (2011-2014) 🔬 Co-Director, Laboratory Core, Center for Oral Health Research (2014-2017) 🏥
Awards and Honors🏆
Multiple research awards, including significant grants from NIH and other institutions 🎖️ Recognized for contributions to oral health research with multiple publications 📜 Recipient of various institutional fellowships and scholarships
Research Focus:
Dr. Yu’s research investigates molecular signaling in periodontal disease, focusing on immune regulation, inflammatory cytokines, and osteoclastogenesis. The goal is to develop treatments for bone loss and regeneration by understanding immune responses in periodontal tissue. 🧬🦴
CD38 Inhibitor 78c Attenuates Pro-Inflammatory Cytokine Expression and Osteoclastogenesis in Macrophages (Cells, 2024)
GPR40/GPR120 Agonist GW9508 Improves Metabolic Syndrome-Exacerbated Periodontitis in Mice (International Journal of Molecular Sciences, 2024)
Inhibition of Sphingosine-1-Phosphate Receptor 2 by JTE013 Enhanced Alveolar Bone Regeneration by Promoting Angiogenesis (International Journal of Molecular Sciences, 2023)
Inhibition of Sphingosine-1-Phosphate Receptor 2 by JTE013 Promoted Osteogenesis by Increasing Vesicle Trafficking (International Journal of Molecular Sciences, 2021)
Targeting S1PRs as a Therapeutic Strategy for Inflammatory Bone Loss Diseases (International Journal of Molecular Sciences, 2021)
Conclusion
Dr. Hong Yu’s research in the field of periodontal disease, her leadership within the medical community, and her dedication to advancing the understanding of immune signaling pathways position her as an outstanding candidate for the Best Researcher Award. Her work is not only scientifically significant but holds the promise of improving clinical outcomes for patients suffering from periodontal disease and other inflammatory bone conditions. Expanding her research’s clinical applicability and fostering broader collaborations could further enhance her contributions to oral health and immune response science.